Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Cattaneo

Showing results (41-50 of 145) with videos related to

Pageof 15
Sort By:
Annals of Hematology|February 22, 2012
P. aeruginosa bloodstream infections among hematological patients: an old or new question?Chiara Cattaneo, F Antoniazzi, S Casari, et al.
Blood Reviews|September 30, 2016
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendationsLivio Pagano, Alessandro Busca, Anna Candoni, et al.
American Journal of Hematology|April 4, 2020
Transplant eligibility in elderly multiple myeloma patients: Prospective external validation of the international myeloma working group frailty score and comparison with clinical judgment and other comorbidity scores in unselected patients aged 65-75 yearsAngelo Belotti, Rossella Ribolla, Valeria Cancelli, et al.
British Journal of Haematology|November 18, 2025
ET occurring in NPM1-mutated AML during molecular complete remission: A further potential evolution of a complex diseaseDiego Bertoli, Carlotta Giupponi, Giuseppe Rossi, et al.
Plos One|December 29, 2012
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortalityMario Tumbarello, Enrico Maria Trecarichi, Morena Caira, et al.
Blood|November 20, 2004
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trialsMichele Spina, Ulrich Jaeger, Joseph A Sparano, et al.
Hematological Oncology|February 14, 2023
COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantationLorenzo Masina, Nicola Bianchetti, Angela Passi, et al.
Gaceta Sanitaria|March 11, 2026
European policies on child obesity prevention, health promotion and responsive parenthood within Joint Action Health4EUKidsAngela Giusti, Vincenza Di Stefano, Paola Scardetta, et al.
Cancers|February 27, 2026
Autologous Stem Cell Transplantation in HIV-Positive and HIV-Negative Patients with Lymphoma: A Propensity Score-Matched Comparative AnalysisAlessandro Re, Margherita Oberti, Armando Stabile, et al.
Haematologica|May 14, 2011
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart ProjectLivio Pagano, Morena Caira, Annamaria Nosari, et al.
Pageof 15

Showing results (41-50 of 145) with videos related to

Sort By:
Pageof 15
Annals of Hematology|February 22, 2012
P. aeruginosa bloodstream infections among hematological patients: an old or new question?Chiara Cattaneo, F Antoniazzi, S Casari, et al.
Blood Reviews|September 30, 2016
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendationsLivio Pagano, Alessandro Busca, Anna Candoni, et al.
American Journal of Hematology|April 4, 2020
Transplant eligibility in elderly multiple myeloma patients: Prospective external validation of the international myeloma working group frailty score and comparison with clinical judgment and other comorbidity scores in unselected patients aged 65-75 yearsAngelo Belotti, Rossella Ribolla, Valeria Cancelli, et al.
British Journal of Haematology|November 18, 2025
ET occurring in NPM1-mutated AML during molecular complete remission: A further potential evolution of a complex diseaseDiego Bertoli, Carlotta Giupponi, Giuseppe Rossi, et al.
Plos One|December 29, 2012
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortalityMario Tumbarello, Enrico Maria Trecarichi, Morena Caira, et al.
Blood|November 20, 2004
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trialsMichele Spina, Ulrich Jaeger, Joseph A Sparano, et al.
Hematological Oncology|February 14, 2023
COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantationLorenzo Masina, Nicola Bianchetti, Angela Passi, et al.
Gaceta Sanitaria|March 11, 2026
European policies on child obesity prevention, health promotion and responsive parenthood within Joint Action Health4EUKidsAngela Giusti, Vincenza Di Stefano, Paola Scardetta, et al.
Cancers|February 27, 2026
Autologous Stem Cell Transplantation in HIV-Positive and HIV-Negative Patients with Lymphoma: A Propensity Score-Matched Comparative AnalysisAlessandro Re, Margherita Oberti, Armando Stabile, et al.
Haematologica|May 14, 2011
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart ProjectLivio Pagano, Morena Caira, Annamaria Nosari, et al.
Pageof 15